StreetAlpha.app
Home › Stocks › DNA

Ginkgo Bioworks Holdings, Inc. (DNA)

Healthcare

Ginkgo Bioworks Holdings, Inc. (DNA) is a Healthcare stock tracked by StreetAlpha. DNA reports earnings on Thu, Nov 5, 2026. Over the past 90 days StreetAlpha recorded 1 whale options trade in DNA, 0% of them bullish and 100% bearish. In the past 30 days there were 1 dark pool print.

AI Auto Pilots
Is DNA in one of our four AI portfolios? Sign in free to see
Next report
Nov 5
2026 · Time not announced
Consensus EPS forecast
—
 
Year-ago EPS
—
Not on file
Options-implied move
—
Posted about a week before
Analyst consensus
1 Hold
1 firm · not enough for a consensus
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Ratings · 90 days
1 Hold
1firm
0 Buy1 Hold0 Sell
Only 1 firm rated DNA in the past 90 days, not enough for a consensus
Average 12-month target
Price targets are not shown on this page right now.
Latest rating changes
TD CowenTarget raised
Oct 13Hold—
TD CowenDowngrade
Aug 7Hold—
DateFirmActionRatingPrice target
Oct 13TD CowenTarget raisedHold—
Aug 7TD CowenDowngradeHold—
Loading…

Whale Options Flow

90D
Total alerts
1
Bullish
0
0%
Bearish
1
100%
Date span
Oct 27 – Oct 27
Loading…

Dark Pool

30D
Prints
1
Notional
—
Largest print
—
Loading…

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether DNA is in one of them and how their past DNA trades turned out.

DNA in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered DNA in an article yet. Here's the latest on the wider market.